Assessment of clinical and laboratory presentations of familial hemophagocytic lymphohistiocytosis patients with homozygous W374X mutation

被引:14
|
作者
Balta, Gunay
Okur, Hamza
Unal, Sule
Yarali, Nese [2 ]
Gunes, Adalet Meral [3 ]
Unal, Selma [4 ]
Turker, Meral [5 ]
Gulerf, Elif [6 ]
Ertem, Mehmet [7 ]
Albayrak, Meryem [8 ]
Patiroglu, Turkan [9 ]
Gurgey, Aytemiz [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Pediat, Sect Pediat Hematol, TR-06100 Ankara, Turkey
[2] Diskapi SSK Educ & Res Hosp, Sect Pediat Hematol, Ankara, Turkey
[3] Uludag Univ, Dept Pediat, Sect Pediat Hematol, Bursa, Turkey
[4] Mersin Univ, Dept Pediat, Sect Pediat Hematol, Mersin, Turkey
[5] Tepecik SSK Educ Hosp, Sect Pediat Hematol, Izmir, Turkey
[6] Gaziantep Univ, Sect Pediat Oncol, Oncol Hosp, Gaziantep, Turkey
[7] Ankara Univ, Sect Pediat Hematol, Dept Pediat, TR-06100 Ankara, Turkey
[8] Gazi Univ, Dept Pediat, Sect Pediat Hematol, Ankara, Turkey
[9] Erciyes Univ, Dept Pediat, Sect Pediat Hematol, Kayseri, Turkey
关键词
Familial hemophagocytic lymphohistiocytosis; FHL; Perforin gene; W374X mutation; Clinical implications; Genotype-phenotype; Founder effect; PERFORIN GENE; TURKISH CHILDREN;
D O I
10.1016/j.leukres.2010.02.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Homozygous W374X mutation was identified in unrelated 13 patients (6M/7F) from consanguineous families, 62% of which had history of deceased sibling. Haplotype analysis provided evidence for the probable existence of a founder effect. Age at disease onset ranged from 1 day to 5.5 months (median 2 months). Hepatic dysfunction was observed in 69%, ascite 62%, hypertriglyceridemia 77%, each hyperferritinemia and hypofibrinogenemia 85%, CNS involvement 46% of patients while birth weights were in normal range. Those with very high ferritin (>20,000 ng/ml) had extremely low fibrinogen levels. Two-thirds of patients receiving HLH protocol died within 20 days of therapy. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1012 / 1017
页数:6
相关论文
共 34 条
  • [1] Unusual Clinical Presentations of Familial Hemophagocytic Lymphohistiocytosis Type-2
    Mhatre, Snehal
    Madkaikar, Manisha
    Jijina, Farah
    Ghosh, Kanjaksha
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (08) : E524 - E527
  • [2] Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2
    Meeths, Marie
    Entesarian, Miriam
    Al-Herz, Waleed
    Chiang, Samuel C. C.
    Wood, Stephanie M.
    Al-Ateeqi, Wafa
    Almazan, Francisco
    Boelens, Jaap J.
    Hasle, Henrik
    Ifversen, Marianne
    Lund, Bendik
    van den Berg, J. Merlijn
    Gustafsson, Britt
    Hjelmqvist, Hans
    Nordenskjold, Magnus
    Bryceson, Yenan T.
    Henter, Jan-Inge
    BLOOD, 2010, 116 (15) : 2635 - 2643
  • [3] Familial hemophagocytic lymphohistiocytosis in a girl with a novel homozygous mutation of STX11 A case report
    Guo, Xia
    Jiang, Mingyan
    Tang, Xue
    Li, Qiang
    MEDICINE, 2019, 98 (48)
  • [4] Genetic and clinical characteristics of pediatric patients with familial hemophagocytic lymphohistiocytosis
    Al Ahmari, Ali
    Alsmadi, Osama
    Sheereen, Atia
    Elamin, Tanziel
    Jabr, Amal
    El-Baik, Lina
    Alhissi, Safa
    Al Saud, Bandar
    Al-Awwami, Moheeb
    Al Fawaz, Ibrahim
    Ayas, Mouhab
    Siddiqui, Khawar
    Hawwari, Abbas
    BLOOD RESEARCH, 2021, 56 (02) : 86 - 94
  • [5] Familial Hemophagocytic Lymphohistiocytosis Type 2 in a Chinese Infant with PRF1 Homozygous Mutation: a Case Report
    Ji, Qiong
    Wang, Guohua
    Xu, Wei
    CLINICAL LABORATORY, 2020, 66 (07) : 1411 - 1414
  • [6] Clinical and molecular aspects of Turkish familial hemophagocytic lymphohistiocytosis patients with perforin mutations
    Okur, Hamza
    Balta, Gunay
    Akarsu, Nurten
    Oner, Ahmet
    Patiroglu, Turkan
    Bay, Ali
    Sayli, Tulin
    Unal, Sule
    Gurgey, Aytemiz
    LEUKEMIA RESEARCH, 2008, 32 (06) : 972 - 975
  • [7] Rapid LightCycler assay for identification of the perforin codon 374 Trp→stop mutation in patients and families with hemophagocytic lymphohistiocytosis (HLH)
    zur Stadt, U
    Kabisch, H
    Janka, G
    Schneider, EM
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (01): : 26 - 29
  • [8] Clinical and Laboratory Evaluation of Patients with Familial Hemophagocytic Lymphohistiocytosis in a Single Center; Striking the Importance of Central Nervous System and Hepatic Involvement
    Beken, Burcin
    Aytac, Selin
    Kuskonmaz, Barys
    Balta, Gunay
    Cetin, Mualla
    Gurgey, Aytemiz
    Cetinkaya, Duygu Uckan
    Gumruk, Fatma
    BLOOD, 2014, 124 (21)
  • [9] Recurrent Macrophage Activation Syndrome Associated With Heterozygous Perforin W374X Gene Mutation in a Child with Systemic Juvenile Idiopathic Arthritis
    Unal, Sule
    Balta, Gunay
    Okur, Hamza
    Aytac, Selin
    Cetin, Mualla
    Gumruk, Fatma
    Ozen, Seza
    Gurgey, Aytemiz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (05) : E205 - E208
  • [10] Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)
    Pagel, Julia
    Beutel, Karin
    Lehmberg, Kai
    Koch, Florian
    Maul-Pavicic, Andrea
    Rohlfs, Anna-Katharina
    Al-Jefri, Abdullah
    Beier, Rita
    Ousager, Lilian Bomme
    Ehlert, Karoline
    Gross-Wieltsch, Ute
    Jorch, Norbert
    Kremens, Bernhard
    Pekrun, Arnulf
    Sparber-Sauer, Monika
    Mejstrikova, Ester
    Wawer, Angela
    Ehl, Stephan
    zur Stadt, Udo
    Janka, Gritta
    BLOOD, 2012, 119 (25) : 6016 - 6024